(Oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S267000

Reexamination Certificate

active

07008947

ABSTRACT:
Disclosed are compounds of the formulaand the pharmaceutically acceptable salts thereof where the variables R1, R2, A, R4, R5, R6, R6′, n, and W are defined herein. These compounds bind to the benzodiazepine site of GABAAreceptors are provided and, therefore can be used to modulate ligand binding to GABAAreceptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) disorders in humans, domesticated companion animals and livestock animals.

REFERENCES:
patent: 4950585 (1990-08-01), Tachibana et al.
patent: 2003/0176450 (2003-09-01), Atkinson et al.
patent: 0 591 528 (1994-04-01), None
patent: 0 795 555 (1997-09-01), None
patent: 2 157 285 (1985-10-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

(Oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with (Oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3613798

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.